Transdermal Matrix Fentanyl Membrane Patch (Matrifen®): In Severe Cancer-Related Chronic Pain

Author： Hair Philip I.   Keating Gillian M.   McKeage Kate  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.68, Iss.14, 2008-01, pp. : 2001-2009

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fentanyl Transdermal Matrix Patch (Durotep® MT Patch; Durogesic® DTrans®; Durogesic® SMAT): In Adults with Cancer-Related Pain

By Hoy Sheridan M.   Keating Gillian M.  

Drugs, Vol. 68, Iss. 12, 2008-01 ,pp. : 1711-1721

Adis International

Access to resources Recommend Favorite

Efficacy, Safety and Pharmacokinetic Study of a Novel Fentanyl-Containing Matrix Transdermal Patch System in Japanese Patients with Cancer Pain

By Miyazaki Toyo  

Clinical Drug Investigation, Vol. 28, Iss. 5, 2008-01 ,pp. : 313-325

Adis International

Access to resources Recommend Favorite

Fentanyl transdermal system vs oxycodone for chronic pain

By  

Inpharma, Vol. 1, Iss. 1339, 2002-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Transdermal fentanyl thwarts cancer pain, revives QOL

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 449, 2004-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Pain Recurrence on the Third Day after Application of a Transdermal Fentanyl Patch

By Konishi Hiroki   Ishihara Chie   Chiba Mikio   Endo Yoshihiro   Yamaji Akira  

Pharmacy World and Science, Vol. 27, Iss. 4, 2005-08 ,pp. : 353-353

Springer Publishing Company

Access to resources Recommend Favorite